Stories about guidance
From today, specialist clinicians can prescribe cannabis-based medicines in the UK to patients with “exceptional clinical need”. They will no longer need to apply to an expert panel for a licence.
The UK government has rescheduled cannabis-based medicines under the Misuse of Drugs regulations 2001. They are now no longer listed under Schedule 1 alongside substances considered to have no therapeutic effect.
Epilepsy Action senior policy and campaigns officer Sam Mountney provides an update on the current situation with cannabis-based medicines in the UK
"Medicinal cannabis is never far away from the news at the moment. We said we’d follow this issue closely on behalf of the epilepsy community so here’s our take on what’s happened so far and what is happening next.